Van Balken MR - Search Results

1

Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.

De Vries TJ, Mooy CM, Van Balken MR, Luyten GP, Quax PH, Verspaget HW, Weidle UH, Ruiter DJ, Van Muijen GN. De Vries TJ, et al. Among authors: van balken mr, van muijen gn. J Pathol. 1995 Jan;175(1):59-67. doi: 10.1002/path.1711750110. J Pathol. 1995. PMID: 7891228 Free article.

2

Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas.

de Kok JB, van Balken MR, Roelofs RW, van Aarssen YA, Swinkels DW, Klein Gunnewiek JM. de Kok JB, et al. Among authors: van balken mr, van aarssen ya. Clin Chem. 2000 Dec;46(12):2003-7. Clin Chem. 2000. PMID: 11106338 No abstract available.

3

Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer.

Witjes JA, van der Poel HG, van Balken MR, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: van balken mr, van der poel hg. Eur Urol. 1998;33(4):387-91. doi: 10.1159/000019621. Eur Urol. 1998. PMID: 9612682

4

The prognostic value of a primary inverted papilloma of the urinary tract.

Witjes JA, van Balken MR, van de Kaa CA. Witjes JA, et al. Among authors: van balken mr, van de kaa ca. J Urol. 1997 Oct;158(4):1500-5. J Urol. 1997. PMID: 9302151 Free article. Review.

5

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: van balken mr. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

6

Detection of telomerase activity in urine as a tool for noninvasive detection of recurrent bladder tumors is poor and cannot be improved by timing of sampling.

de Kok JB, van Balken MR, Ruers TJ, Swinkels DW, Klein Gunnewiek JM. de Kok JB, et al. Among authors: van balken mr. Clin Chem. 2000 Dec;46(12):2014-5. Clin Chem. 2000. PMID: 11106340 No abstract available.

7

Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data.

Vandoninck V, van Balken MR, Finazzi Agrò E, Petta F, Micali F, Heesakkers JP, Debruyne FM, Kiemeney LA, Bemelmans BL. Vandoninck V, et al. Among authors: van balken mr. Neurourol Urodyn. 2003;22(3):227-32. doi: 10.1002/nau.10111. Neurourol Urodyn. 2003. PMID: 12707873 Clinical Trial.

8

Implant-Driven Tibial Nerve Stimulation in the Treatment of Refractory Overactive Bladder Syndrome: 12-Month Follow-up.

van der Pal F, van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL. van der Pal F, et al. Among authors: van balken mr. Neuromodulation. 2006 Apr;9(2):163-71. doi: 10.1111/j.1525-1403.2006.00056.x. Neuromodulation. 2006. PMID: 22151641

9

Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data.

Vandoninck V, van Balken MR, Finazzi Agrò E, Heesakkers JP, Debruyne FM, Kiemeney LA, Bemelmans BL. Vandoninck V, et al. Among authors: van balken mr. Neurourol Urodyn. 2004;23(3):246-51. doi: 10.1002/nau.10158. Neurourol Urodyn. 2004. PMID: 15098221

10

Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation.

van der Pal F, van Balken MR, Heesakkers JP, Debruyne FM, Kiemeney LA, Bemelmans BL. van der Pal F, et al. Among authors: van balken mr. BJU Int. 2006 Jan;97(1):113-6. doi: 10.1111/j.1464-410X.2006.05860.x. BJU Int. 2006. PMID: 16336339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters